Fang Guo of Cornerstone Research will join a panel titled “Determining Damages and Negotiating BPCIA Settlements Without Becoming an FTC Target.”
On the second day of the conference, Dr. Guo’s panel will discuss strategies for parties negotiating Biologics Price Competition and Innovation Act (BPCIA) settlements.
Key topics will include:
- How courts evaluate lost profits, reasonable royalties, at-risk launch exposure, and market-share allocation
- Strategies for negotiating launch triggers and volume limitations
- The Federal Trade Commission’s (FTC’s) approach to drug listings and its influence on drug patenting and market exclusivity
Cornerstone Research is a sponsor of this event, hosted by the American Conference Institute. For more information, visit the event website.
Boston
